Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/164841 |
Resumo: | The Ginoide Hydrolipodystrophy (GHLD), commonly known as cellulite, occurs in 80-90% of the female population after the puberty period and comes from a metabolic modification in the cutaneous adipose tissue. Caffeine has been used in topical formulations due to its lipolytic action. We studied a nanoemulsion (F3) containing caffeine with two surfactants (oleth-3 and oleth-20) by emulsification method by phase inversion temperature inversion (PIT). The polydispersion indices (PDI) showed the reduced deviation of 0.1. The mean droplet size was ~ 40 nm. The evaluated constant of Ostwald, in the refrigerator condition was the most favorable during the stability test. In the In Raman spectroscopy assay, the caffeine bands found in F3 were compatible with those found in the caffeine solution (1337, 652.5 and 558.2 cm-1). There was no interaction of caffeine anhydrous with other ingredients in nanoemulsion. In the in vitro safety assay the result of 1.4 ranked the F3 as slightly irritating. In the natural membrane, cutaneous permeation test (human skin) permeate concentrations did not exceed the saturation concentration of the PBS buffer (48.96 μg/3 mL). The caffeine solution and F3 permeated statistically equal, but the nanoemulsion visually and sensorially improved the caffeine precipitation. |
id |
USP-31_37b5bcfaf921482c05e98a4927d80d77 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/164841 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluationCelluliteCaffeineGynoid hydrolipodystrophyNanoemulsionPermeationThe Ginoide Hydrolipodystrophy (GHLD), commonly known as cellulite, occurs in 80-90% of the female population after the puberty period and comes from a metabolic modification in the cutaneous adipose tissue. Caffeine has been used in topical formulations due to its lipolytic action. We studied a nanoemulsion (F3) containing caffeine with two surfactants (oleth-3 and oleth-20) by emulsification method by phase inversion temperature inversion (PIT). The polydispersion indices (PDI) showed the reduced deviation of 0.1. The mean droplet size was ~ 40 nm. The evaluated constant of Ostwald, in the refrigerator condition was the most favorable during the stability test. In the In Raman spectroscopy assay, the caffeine bands found in F3 were compatible with those found in the caffeine solution (1337, 652.5 and 558.2 cm-1). There was no interaction of caffeine anhydrous with other ingredients in nanoemulsion. In the in vitro safety assay the result of 1.4 ranked the F3 as slightly irritating. In the natural membrane, cutaneous permeation test (human skin) permeate concentrations did not exceed the saturation concentration of the PBS buffer (48.96 μg/3 mL). The caffeine solution and F3 permeated statistically equal, but the nanoemulsion visually and sensorially improved the caffeine precipitation.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/16484110.1590/s2175-97902019000218236Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18236Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e18236Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e182362175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/164841/158007Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFreire, Thamires BatelloDario, Michelli FerreraMendes, Otávio GilOliveira, Andressa Costa deVetore Neto, AlbertoFaria, Dalva Lucia Araújo deSilva, Vânia Rodrigues Leite eBaby, André RolimVelasco, Maria Valéria Robles2021-01-11T18:56:44Zoai:revistas.usp.br:article/164841Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-01-11T18:56:44Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation |
title |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation |
spellingShingle |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation Freire, Thamires Batello Cellulite Caffeine Gynoid hydrolipodystrophy Nanoemulsion Permeation |
title_short |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation |
title_full |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation |
title_fullStr |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation |
title_full_unstemmed |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation |
title_sort |
Nanoemulsion containing caffeine for cellulite treatment: characterization and in vitro evaluation |
author |
Freire, Thamires Batello |
author_facet |
Freire, Thamires Batello Dario, Michelli Ferrera Mendes, Otávio Gil Oliveira, Andressa Costa de Vetore Neto, Alberto Faria, Dalva Lucia Araújo de Silva, Vânia Rodrigues Leite e Baby, André Rolim Velasco, Maria Valéria Robles |
author_role |
author |
author2 |
Dario, Michelli Ferrera Mendes, Otávio Gil Oliveira, Andressa Costa de Vetore Neto, Alberto Faria, Dalva Lucia Araújo de Silva, Vânia Rodrigues Leite e Baby, André Rolim Velasco, Maria Valéria Robles |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Freire, Thamires Batello Dario, Michelli Ferrera Mendes, Otávio Gil Oliveira, Andressa Costa de Vetore Neto, Alberto Faria, Dalva Lucia Araújo de Silva, Vânia Rodrigues Leite e Baby, André Rolim Velasco, Maria Valéria Robles |
dc.subject.por.fl_str_mv |
Cellulite Caffeine Gynoid hydrolipodystrophy Nanoemulsion Permeation |
topic |
Cellulite Caffeine Gynoid hydrolipodystrophy Nanoemulsion Permeation |
description |
The Ginoide Hydrolipodystrophy (GHLD), commonly known as cellulite, occurs in 80-90% of the female population after the puberty period and comes from a metabolic modification in the cutaneous adipose tissue. Caffeine has been used in topical formulations due to its lipolytic action. We studied a nanoemulsion (F3) containing caffeine with two surfactants (oleth-3 and oleth-20) by emulsification method by phase inversion temperature inversion (PIT). The polydispersion indices (PDI) showed the reduced deviation of 0.1. The mean droplet size was ~ 40 nm. The evaluated constant of Ostwald, in the refrigerator condition was the most favorable during the stability test. In the In Raman spectroscopy assay, the caffeine bands found in F3 were compatible with those found in the caffeine solution (1337, 652.5 and 558.2 cm-1). There was no interaction of caffeine anhydrous with other ingredients in nanoemulsion. In the in vitro safety assay the result of 1.4 ranked the F3 as slightly irritating. In the natural membrane, cutaneous permeation test (human skin) permeate concentrations did not exceed the saturation concentration of the PBS buffer (48.96 μg/3 mL). The caffeine solution and F3 permeated statistically equal, but the nanoemulsion visually and sensorially improved the caffeine precipitation. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12-06 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/164841 10.1590/s2175-97902019000218236 |
url |
https://www.revistas.usp.br/bjps/article/view/164841 |
identifier_str_mv |
10.1590/s2175-97902019000218236 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/164841/158007 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18236 Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e18236 Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18236 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222914525528064 |